Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 3
2008 4
2010 1
2011 4
2012 4
2013 6
2014 4
2015 4
2016 5
2017 6
2018 5
2019 6
2020 3
2021 3
2022 3
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
T315I+ tyrosine-kinase independent CML cells resistance.
Nicolini FE, Grockowiak E, Maguer-Satta V. Nicolini FE, et al. Oncotarget. 2017 Jul 4;8(27):43600-43601. doi: 10.18632/oncotarget.18573. Oncotarget. 2017. PMID: 28642447 Free PMC article. No abstract available.
First-line second generation tyrosine kinase inhibitors in patients with newly diagnosed accelerated phase chronic myeloid leukemia.
Balsat M, Alcazer V, Etienne G, Huguet F, Berger M, Cayssials E, Charbonnier A, Escoffre-Barbe M, Johnson-Ansah H, Legros L, Roy L, Delmer A, Ianotto JC, Orvain C, Larosa F, Meunier M, Amé S, Andreoli A, Cony-Makhoul P, Morisset S, Tigaud I, Rea D, Nicolini FE. Balsat M, et al. Among authors: nicolini fe. Leuk Res. 2023 Jul;130:107308. doi: 10.1016/j.leukres.2023.107308. Epub 2023 May 9. Leuk Res. 2023. PMID: 37230027
Clinical outcome of therapy-related acute myeloid leukemia patients. Real-life experience in a University Hospital and a Cancer Center in France.
Belhabri A, Heiblig M, Morisset S, Vila L, Santana C, Nicolas-Virelizier E, Hayette S, Tigaud I, Plesa A, Labussiere-Wallet H, Sobh M, Michallet AS, Marie B, Nicolini FE, Guillermin Y, Gaëlle F, Lebras L, Rey P, Jauffret-Bertholon L, Laude MC, Sandrine L, Michallet M. Belhabri A, et al. Among authors: nicolini fe. Cancer Med. 2023 Aug;12(16):16929-16944. doi: 10.1002/cam4.6322. Epub 2023 Aug 7. Cancer Med. 2023. PMID: 37548369 Free PMC article.
Onset of blast crisis in chronic myeloid leukemia patients in treatment-free remission.
Dulucq S, Hayette S, Cayuela JM, Bauduer F, Chabane K, Chevallier P, Cony-Makhoul P, Flandrin-Gresta P, Jeune CL, Bris YL, Legros L, Maisonneuve H, Roy L, Mahon FX, Sloma I, Rea D, Nicolini FE. Dulucq S, et al. Among authors: nicolini fe. Haematologica. 2022 Dec 1;107(12):2944-2949. doi: 10.3324/haematol.2022.280740. Haematologica. 2022. PMID: 35924576 Free PMC article. No abstract available.
Dose optimisation of ponatinib in chronic phase chronic myeloid leukemia.
Huguet F, Réa D, Cayssials E, Etienne G, Nicolini FE. Huguet F, et al. Among authors: nicolini fe. Expert Rev Hematol. 2023 Jul-Dec;16(9):633-639. doi: 10.1080/17474086.2023.2234084. Epub 2023 Jul 27. Expert Rev Hematol. 2023. PMID: 37427999 Clinical Trial.
Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia.
Gambacorti-Passerini C, Nicolini FE, Larson RA, Aroldi A, Fontana D, Piazza R, le Coutre P, Antolini L, Assouline S. Gambacorti-Passerini C, et al. Among authors: nicolini fe. Am J Hematol. 2022 Aug;97(8):E296-E298. doi: 10.1002/ajh.26618. Epub 2022 Jun 9. Am J Hematol. 2022. PMID: 35604243 Free PMC article. No abstract available.
[Recommendations from the French CML Study Group (Fi-LMC) for BCR-ABL1 kinase domain mutation analysis in chronic myeloid leukemia].
Cayuela JM, Chomel JC, Coiteux V, Dulucq S, Escoffre-Barbe M, Etancelin P, Etienne G, Hayette S, Millot F, Nibourel O, Nicolini FE, Réa D; pour la France Intergroupe des leucémies myéloïdes chroniques (Fi-LMC) et le Groupe des biologistes moléculaires des hémopathies malignes (GBMHM). Cayuela JM, et al. Among authors: nicolini fe. Bull Cancer. 2020 Jan;107(1):113-128. doi: 10.1016/j.bulcan.2019.05.011. Epub 2019 Jul 26. Bull Cancer. 2020. PMID: 31353136 Review. French.
56 results